According to an administrative penalty information released by the US Food and Drug Administration in Fujian, Xiamen Aode Biotechnology Co., Ltd. was fined 44,000 yuan for allegedly producing novel coronavirus (20 19-nCoV) antigen detection kit (colloidal gold method) that did not meet the technical requirements of registered products.
Hunan Aode Zhongke Biotechnology Co., Ltd. was established on March 20 15 18. The legal representative is Xie Xiaoying, and the business scope of the company includes: biotechnology promotion services; A class of medical equipment and apparatus manufacturing; A class of medical devices and equipment wholesale; Manufacture of clinical laboratory analytical instruments and in vitro diagnostic reagents.